Teva Falls Most in 8 Weeks as U.S. Court Refuses to Overturn Patent Ruling
Teva Pharmaceutical Industries Ltd. declined the most in almost eight weeks after a U.S. Court denied a motion by the world’s largest maker of generic drugs to overturn a jury verdict on the validity of a Wyeth patent.

Read more on Bloomberg